ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) Q1 2025 Earnings

25MarConfirmed
Q3 2024
Q1 2025
-0.47
-0.14
0.19
0.53

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) will report earnings of for Q1 2025 on March 25, 2025.

0 Comments

Share your thoughts